Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2013 | 12-2012 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 0 | 1,640 |
| Receivables | 0 | 80 |
| Other current assets | 0 | 520 |
| TOTAL | $0 | $2,240 |
| Non-Current Assets | ||
| TOTAL | $N/A | $N/A |
| Total Assets | $0 | $2,240 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 410 |
| Accrued Expenses | 0 | 350 |
| Other current liabilities | 0 | 4,150 |
| TOTAL | $0 | $4,920 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $0 | $4,920 |
| Shareholders' Equity | ||
| Retained earnings | 0 | -59,580 |
| Other shareholders' equity | 0 | 56,910 |
| TOTAL | $0 | $-2,670 |
| Total Liabilities And Equity | $0 | $2,250 |